MD
MiMedx Group, Inc.
MDXG · NASDAQ
$4.81 +0.31% (+$0.01)
1M +12.65%
Market Cap $701.1M
P/E Ratio 112.41x
Div. Yield -
ROE 2.61%
Bulios Fair Price
$5.76
19.8% upside
Current Price
$4.81
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MDXG is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
44 /100
Fair P/FCF 17.28x
P/E 112.41x
P/B 3.25x
Growth
94 /100
Growing Book val. growth 51.01%
Rev. growth 16.05%
FCF growth N/A
Profitability
48 /100
Moderate Op. margin 2.46%
Gross margin 78.85%
FCF margin 11.42%
Quality
24 /100
Poor ROA 2.22%
ROIC 1.94%
Asset turnover 1.26x
Debt
94 /100
Low Int. coverage 7.56x
Debt/Equity 0.01x
Net debt/EBITDA -5.67x
Stability
48 /100
Moderate EPS volatility 143.90%
Beta 1.42x
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MDXG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Joseph H. Capper
Employees
808
Headquarters
Marietta
Upcoming events
04 NOV
Earnings
Upcoming earnings report